ACM
MRK icon

Aljian Capital Management’s Merck MRK Stock Holding History

Aljian Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$765K Sell
5,955
-16
-0.3% -$1.87K 0.14% 73
2026
Q1 		$718K Buy
5,971
+22
+0.4% +$2.54K 0.15% 71
2025
Q4 		$626K Buy
5,949
+33
+0.6% +$3.1K 0.12% 76
2025
Q3 		$497K Sell
5,916
-31
-0.5% -$2.55K 0.1% 85
2025
Q2 		$471K Sell
5,947
-193
-3% -$15.3K 0.1% 86
2025
Q1 		$551K Buy
6,140
+141
+2% +$13.2K 0.13% 81
2024
Q4 		$597K Sell
5,999
-118
-2% -$12.2K 0.13% 73
2024
Q3 		$695K Buy
+6,117
New +$727K 0.16% 66

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aljian Capital Management's MRK Position: Q2 2026 in Review

Aljian Capital Management reduced its Merck (MRK) stake by 0.27% in Q2 2026, selling an estimated $1.87K and leaving 5,955 shares worth $765K. The position accounts for 0.14% of the portfolio, ranked #73.

Aljian Capital Management first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aljian Capital Management held 5,955 shares of Merck worth $765K as of Q2 2026.
  • Aljian Capital Management sold 16 Merck shares in Q2 2026, an estimated $1.87K.
  • Merck made up 0.14% of Aljian Capital Management's portfolio in Q2 2026, its #73 holding.
  • Aljian Capital Management first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aljian Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.